5.17
-0.26 (-4.79%)
-0.26 (-4.79%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| OncoSec Medical Incorporated | ONCS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.26 | -4.79% | 5.17 | 00:00:08 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 5.43 | 5.12 | 5.55 | 5.17 | 5.43 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 1.40 | 7.37 | 5.97 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,110 | 159,759 | $ 5.31 | $ 847,665 | 362,404 | 1.40 - 8.1598 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 2,366 | $ 5.17 | USD |
OncoSec Medical Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 144.71M | 27.99M | 15.87M | $ - | $ - | -2.89 | -2.90 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
OncoSec Medical News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ONCS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.15 | 5.55 | 5.05 | 5.28 | 173,145 | 0.02 | 0.39% |
| 1 Month | 5.50 | 6.28 | 4.45 | 5.39 | 170,026 | -0.33 | -6.0% |
| 3 Months | 6.33 | 8.1598 | 4.45 | 6.45 | 309,488 | -1.16 | -18.33% |
| 6 Months | 3.70 | 8.1598 | 3.35 | 5.86 | 288,039 | 1.47 | 39.73% |
| 1 Year | 1.59 | 8.1598 | 1.40 | 4.34 | 309,857 | 3.58 | 225.16% |
| 3 Years | 20.70 | 21.00 | 1.03 | 9.16 | 546,473 | -15.53 | -75.02% |
| 5 Years | 23.90 | 34.90 | 1.03 | 12.88 | 581,578 | -18.73 | -78.37% |
OncoSec Medical Description
| OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer. |
